Isofol announces that an abstract, including arfolitixorin in the ISO-CC-005 study, has been accepted to be presented at ASCO GI in January 2021. The upcoming congress American Society of Clinical Oncology Gastrointestinal (ASCO GI), taking place in January 15-17, 2021, will be a virtual exhibition. In connection to this Isofol, together with QuartzBio, The Sahlgrenska Academy of Gothenburg and Sahlgrenska University, will present a poster including arfolitixorin from the ISO-CC-005 study.
Folate pathway gene expression in metastatic colorectal cancer patients treated with arfolitixorin/5-FU-based chemotherapy.
Roger Tell, Alessandro Di Cara, Elisabeth Odin, Göran U. Carlsson, Yvonne Wettergren
When the poster will be presented at ASCO GI, it will also be published on Isofol’s website.